Biosimilars in inflammatory bowel disease

被引：2
|
作者：
Moore, Gregory T. [1 ,2 ]
机构：
[1] Monash Hlth, Clayton, Vic, Australia
[2] Monash Univ, Clayton, Vic, Australia
来源：
MEDICAL JOURNAL OF AUSTRALIA | 2016年 / 205卷 / 07期
关键词：
D O I：
10.5694/mja16.00775
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：294 / 295
页数：2
相关论文
共 50 条
  • [41] Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
    Najeeb, Hala
    Yasmin, Farah
    Surani, Salim
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (14) : 4327 - 4333
  • [42] Benefits of Biosimilars in the Management of Patients with Inflammatory Bowel Disease: An International Survey
    D'Amico, Ferdinando
    Peyrin-Biroulet, Laurent
    Danese, Silvio
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (11)
  • [43] USE OF BIOSIMILARS TO INFLIXIMAB DURING PREGNANCY IN WOMEN WITH INFLAMMATORY BOWEL DISEASE
    Long, Millie D.
    Kane, Sunanda V.
    Beaulieu, Dawn
    Abraham, Bincy P.
    Zhang, Xian
    Mahadevan, Uma
    GASTROENTEROLOGY, 2024, 166 (05) : S1153 - S1154
  • [44] Emerging role of biosimilars in the clinical care of inflammatory bowel disease patients
    Hala Najeeb
    Farah Yasmin
    Salim Surani
    World Journal of Clinical Cases, 2022, (14) : 4327 - 4333
  • [45] Biosimilars in inflammatory bowel disease: A review of post-marketing experience
    Deiana, Simona
    Gabbani, Tommaso
    Annese, Vito
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (02) : 197 - 203
  • [46] Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists
    Bokemeyer, Bernd
    Dignass, Axel
    Schreiber, Stefan
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2017, 55 (04): : 369 - 374
  • [47] Use of biosimilars in inflammatory bowel disease: a position update of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)
    Fiorino, Gionata
    Caprioli, Flavio
    Daperno, Marco
    Mocciaro, Filippo
    Principi, Mariabeatrice
    Viscido, Angelo
    Fantini, Massimo Claudio
    Orlando, Ambrogio
    Papi, Claudio
    Annese, Vito
    Danese, Silvio
    Vecchi, Maurizio
    Rizzello, Fernando
    Armuzzi, Alessandro
    Leone, Salvatore
    Previtali, Enrica
    Aloi, Marina
    Alvisi, Patrizia
    Antonelli, Elisabetta
    Ardizzone, Sandro
    Astegiano, Marco
    Baldoni, Monia
    Beltrami, Marina
    Biancone, Livia
    Bodini, Giorgia
    Buda, Andrea
    Bossa, Fabrizio
    Bracci, Fiammetta
    Calabrese, Emma
    Cappello, Maria
    Castiglione, Fabiana
    Ciacci, Carolina
    Cicala, Michele
    Ciccocioppo, Rachele
    Comberlato, Michele
    Cortelezzi, Claudio Camillo
    Cosintino, Rocco
    Costa, Francesco
    Costantino, Giuseppe
    Cucchiara, Salvatore
    Cuomo, Antonio
    D'Inca, Renata
    Di Paolo, Maria Carla
    Di Sabatino, Antonio
    Di Sario, Antonio
    Frieri, Giuseppe
    Fries, Walter
    Gasbarrini, Antonio
    Geccherle, Andrea
    Gionchetti, Paolo
    DIGESTIVE AND LIVER DISEASE, 2019, 51 (05) : 632 - 639
  • [48] Role of biologics and biosimilars in inflammatory bowel disease: current trends and future perspectives
    Rawla, Prashanth
    Sunkara, Tagore
    Raj, Jeffrey Pradeep
    JOURNAL OF INFLAMMATION RESEARCH, 2018, 11 : 215 - 226
  • [49] Does Similarity Breed Contempt? A Review of the Use of Biosimilars in Inflammatory Bowel Disease
    Bhat, Shubha
    Limdi, Jimmy K.
    Cross, Raymond K.
    Farraye, Francis A.
    DIGESTIVE DISEASES AND SCIENCES, 2021, 66 (08) : 2513 - 2532
  • [50] Systematic Review of Evidence for Monoclonal Antibody Biosimilars for the Treatment of Inflammatory Bowel Disease
    Petersel, Danielle
    Cheung, Raymond
    Sewell, K. Lea
    Singh, Ena
    Isakov, Leah
    Jacobs, Ira
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S30 - S30
12345